Part 7/7:
As technology and healthcare sectors converge, the opportunities for investment and innovation will only expand. Gilead's focus on gene therapy and Apple's healthcare initiatives suggest each company is looking to redefine the future of medicine. Stakeholders, from investors to consumers, should remain alert to these evolving landscapes for potential opportunities and challenges alike. The next few years will undoubtedly be pivotal in reshaping how healthcare is delivered and experienced.